Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs SoFi Technologies Inc (SOFI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs SoFi Technologies Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while SoFi Technologies Inc trades at $14.1 (market cap $19.68B). The key difference: SoFi Technologies Inc is far larger — about 2.2× Kymera Therapeutics Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, SoFi Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and SoFi Technologies Inc for 60 Days on average.
| KYMR | SOFI | |
|---|---|---|
Market Cap | $8.87B | $19.68B |
Volume | 779,107 | 30,790,556 |
Sector | Health | Financials |
52-Week High | $127.31 | $32.21 |
52-Week Low | $55.80 | $14.22 |
Typical Hold Time | 0 Days | 60 Days |
Enterprise Value | $8.26B | $19.83B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SoFi Technologies stock trades at $14.22, down 6.63% with bearish technical signals. The company shows strong revenue growth from $2.6B in 2024 to $3.6B in 2025, with consistent earnings beats. However, negative operating cash flow and high P/E ratio of 31.1 present valuation concerns. Recent news highlights SoFi's stablecoin initiatives and record loan originations while the stock faces pressure from rising yields.
SoFi offers growth potential with expanding financial services but faces execution risks in a competitive fintech landscape. The stock trades at a discount to analyst consensus target of $21.08, though negative cash flow trends and market sensitivity to interest rates warrant caution. Investors should weigh strong fundamentals against technical weakness and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About SoFi Technologies Inc
SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →
